カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の麻疹弱毒生ワクチン市場2023年：企業・地域・タイプ・用途別分析

◆英語タイトル：Global Measles Attenuated Live Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが発行した調査報告書（GIR23SM7921）◆商品コード：GIR23SM7921
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2023年9月
◆ページ数：100
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

GlobalInfoResearchの最新の調査によると、世界の麻疹弱毒生ワクチンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の麻疹弱毒生ワクチン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 麻疹弱毒生ワクチンの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

麻疹弱毒生ワクチン市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・粉末、液体

用途別セグメント
・病院、診療所

主要な市場プレーヤー
・Merck、Pfizer、Serum Institute of India、GSK、Sanofi-Pasteur、Novartis、Bavarian Nordic、Medimmune、Changchun Keygen Biological Products、Shanghai Institute of Biological Products、Wuhan Institute of Biological Products、Lanzhou Institute of Biological Products

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、麻疹弱毒生ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な麻疹弱毒生ワクチンメーカーの企業概要、2019年～2022年までの麻疹弱毒生ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な麻疹弱毒生ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別麻疹弱毒生ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの麻疹弱毒生ワクチンのタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での麻疹弱毒生ワクチン市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および麻疹弱毒生ワクチンの産業チェーンを掲載しています。
・第14、15章では、麻疹弱毒生ワクチンの販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 麻疹弱毒生ワクチンの概要
– タイプ別分析（2018年vs2022年vs2029年）：粉末、液体
– 用途別分析（2018年vs2022年vs2029年）：病院、診療所
– 世界の麻疹弱毒生ワクチン市場規模・予測
– 世界の麻疹弱毒生ワクチン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Merck、Pfizer、Serum Institute of India、GSK、Sanofi-Pasteur、Novartis、Bavarian Nordic、Medimmune、Changchun Keygen Biological Products、Shanghai Institute of Biological Products、Wuhan Institute of Biological Products、Lanzhou Institute of Biological Products
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：粉末、液体
・用途別分析2018年-2029年：病院、診療所
・麻疹弱毒生ワクチンの北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・麻疹弱毒生ワクチンのヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・麻疹弱毒生ワクチンのアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・麻疹弱毒生ワクチンの南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・麻疹弱毒生ワクチンの中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

❖ レポートの目次 ❖

1 Market Overview
1.1 Product Overview and Scope of Measles Attenuated Live Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Measles Attenuated Live Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Powder
1.3.3 Liquid
1.4 Market Analysis by Application
1.4.1 Overview: Global Measles Attenuated Live Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Measles Attenuated Live Vaccine Market Size & Forecast
1.5.1 Global Measles Attenuated Live Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Measles Attenuated Live Vaccine Sales Quantity (2018-2029)
1.5.3 Global Measles Attenuated Live Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Measles Attenuated Live Vaccine Product and Services
2.1.4 Merck Measles Attenuated Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Measles Attenuated Live Vaccine Product and Services
2.2.4 Pfizer Measles Attenuated Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Pfizer Recent Developments/Updates
2.3 Serum Institute of India
2.3.1 Serum Institute of India Details
2.3.2 Serum Institute of India Major Business
2.3.3 Serum Institute of India Measles Attenuated Live Vaccine Product and Services
2.3.4 Serum Institute of India Measles Attenuated Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Serum Institute of India Recent Developments/Updates
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK Measles Attenuated Live Vaccine Product and Services
2.4.4 GSK Measles Attenuated Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 GSK Recent Developments/Updates
2.5 Sanofi-Pasteur
2.5.1 Sanofi-Pasteur Details
2.5.2 Sanofi-Pasteur Major Business
2.5.3 Sanofi-Pasteur Measles Attenuated Live Vaccine Product and Services
2.5.4 Sanofi-Pasteur Measles Attenuated Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sanofi-Pasteur Recent Developments/Updates
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Measles Attenuated Live Vaccine Product and Services
2.6.4 Novartis Measles Attenuated Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Novartis Recent Developments/Updates
2.7 Bavarian Nordic
2.7.1 Bavarian Nordic Details
2.7.2 Bavarian Nordic Major Business
2.7.3 Bavarian Nordic Measles Attenuated Live Vaccine Product and Services
2.7.4 Bavarian Nordic Measles Attenuated Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Bavarian Nordic Recent Developments/Updates
2.8 Medimmune
2.8.1 Medimmune Details
2.8.2 Medimmune Major Business
2.8.3 Medimmune Measles Attenuated Live Vaccine Product and Services
2.8.4 Medimmune Measles Attenuated Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Medimmune Recent Developments/Updates
2.9 Changchun Keygen Biological Products
2.9.1 Changchun Keygen Biological Products Details
2.9.2 Changchun Keygen Biological Products Major Business
2.9.3 Changchun Keygen Biological Products Measles Attenuated Live Vaccine Product and Services
2.9.4 Changchun Keygen Biological Products Measles Attenuated Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Changchun Keygen Biological Products Recent Developments/Updates
2.10 Shanghai Institute of Biological Products
2.10.1 Shanghai Institute of Biological Products Details
2.10.2 Shanghai Institute of Biological Products Major Business
2.10.3 Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Product and Services
2.10.4 Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Shanghai Institute of Biological Products Recent Developments/Updates
2.11 Wuhan Institute of Biological Products
2.11.1 Wuhan Institute of Biological Products Details
2.11.2 Wuhan Institute of Biological Products Major Business
2.11.3 Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Product and Services
2.11.4 Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Wuhan Institute of Biological Products Recent Developments/Updates
2.12 Lanzhou Institute of Biological Products
2.12.1 Lanzhou Institute of Biological Products Details
2.12.2 Lanzhou Institute of Biological Products Major Business
2.12.3 Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Product and Services
2.12.4 Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Lanzhou Institute of Biological Products Recent Developments/Updates
3 Competitive Environment: Measles Attenuated Live Vaccine by Manufacturer
3.1 Global Measles Attenuated Live Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Measles Attenuated Live Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Measles Attenuated Live Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Measles Attenuated Live Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Measles Attenuated Live Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Measles Attenuated Live Vaccine Manufacturer Market Share in 2022
3.5 Measles Attenuated Live Vaccine Market: Overall Company Footprint Analysis
3.5.1 Measles Attenuated Live Vaccine Market: Region Footprint
3.5.2 Measles Attenuated Live Vaccine Market: Company Product Type Footprint
3.5.3 Measles Attenuated Live Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Measles Attenuated Live Vaccine Market Size by Region
4.1.1 Global Measles Attenuated Live Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Measles Attenuated Live Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Measles Attenuated Live Vaccine Average Price by Region (2018-2029)
4.2 North America Measles Attenuated Live Vaccine Consumption Value (2018-2029)
4.3 Europe Measles Attenuated Live Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Measles Attenuated Live Vaccine Consumption Value (2018-2029)
4.5 South America Measles Attenuated Live Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Measles Attenuated Live Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Measles Attenuated Live Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Measles Attenuated Live Vaccine Consumption Value by Type (2018-2029)
5.3 Global Measles Attenuated Live Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Measles Attenuated Live Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Measles Attenuated Live Vaccine Consumption Value by Application (2018-2029)
6.3 Global Measles Attenuated Live Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America Measles Attenuated Live Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Measles Attenuated Live Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Measles Attenuated Live Vaccine Market Size by Country
7.3.1 North America Measles Attenuated Live Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Measles Attenuated Live Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Measles Attenuated Live Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Measles Attenuated Live Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Measles Attenuated Live Vaccine Market Size by Country
8.3.1 Europe Measles Attenuated Live Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Measles Attenuated Live Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Measles Attenuated Live Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Measles Attenuated Live Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Measles Attenuated Live Vaccine Market Size by Region
9.3.1 Asia-Pacific Measles Attenuated Live Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Measles Attenuated Live Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Measles Attenuated Live Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Measles Attenuated Live Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Measles Attenuated Live Vaccine Market Size by Country
10.3.1 South America Measles Attenuated Live Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Measles Attenuated Live Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Measles Attenuated Live Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Measles Attenuated Live Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Measles Attenuated Live Vaccine Market Size by Country
11.3.1 Middle East & Africa Measles Attenuated Live Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Measles Attenuated Live Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Measles Attenuated Live Vaccine Market Drivers
12.2 Measles Attenuated Live Vaccine Market Restraints
12.3 Measles Attenuated Live Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Measles Attenuated Live Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Measles Attenuated Live Vaccine
13.3 Measles Attenuated Live Vaccine Production Process
13.4 Measles Attenuated Live Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Measles Attenuated Live Vaccine Typical Distributors
14.3 Measles Attenuated Live Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Measles Attenuated Live Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Measles Attenuated Live Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Measles Attenuated Live Vaccine Product and Services
Table 6. Merck Measles Attenuated Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Major Business
Table 10. Pfizer Measles Attenuated Live Vaccine Product and Services
Table 11. Pfizer Measles Attenuated Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Pfizer Recent Developments/Updates
Table 13. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 14. Serum Institute of India Major Business
Table 15. Serum Institute of India Measles Attenuated Live Vaccine Product and Services
Table 16. Serum Institute of India Measles Attenuated Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Serum Institute of India Recent Developments/Updates
Table 18. GSK Basic Information, Manufacturing Base and Competitors
Table 19. GSK Major Business
Table 20. GSK Measles Attenuated Live Vaccine Product and Services
Table 21. GSK Measles Attenuated Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. GSK Recent Developments/Updates
Table 23. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi-Pasteur Major Business
Table 25. Sanofi-Pasteur Measles Attenuated Live Vaccine Product and Services
Table 26. Sanofi-Pasteur Measles Attenuated Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Sanofi-Pasteur Recent Developments/Updates
Table 28. Novartis Basic Information, Manufacturing Base and Competitors
Table 29. Novartis Major Business
Table 30. Novartis Measles Attenuated Live Vaccine Product and Services
Table 31. Novartis Measles Attenuated Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Novartis Recent Developments/Updates
Table 33. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 34. Bavarian Nordic Major Business
Table 35. Bavarian Nordic Measles Attenuated Live Vaccine Product and Services
Table 36. Bavarian Nordic Measles Attenuated Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Bavarian Nordic Recent Developments/Updates
Table 38. Medimmune Basic Information, Manufacturing Base and Competitors
Table 39. Medimmune Major Business
Table 40. Medimmune Measles Attenuated Live Vaccine Product and Services
Table 41. Medimmune Measles Attenuated Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Medimmune Recent Developments/Updates
Table 43. Changchun Keygen Biological Products Basic Information, Manufacturing Base and Competitors
Table 44. Changchun Keygen Biological Products Major Business
Table 45. Changchun Keygen Biological Products Measles Attenuated Live Vaccine Product and Services
Table 46. Changchun Keygen Biological Products Measles Attenuated Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Changchun Keygen Biological Products Recent Developments/Updates
Table 48. Shanghai Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 49. Shanghai Institute of Biological Products Major Business
Table 50. Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Product and Services
Table 51. Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Shanghai Institute of Biological Products Recent Developments/Updates
Table 53. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 54. Wuhan Institute of Biological Products Major Business
Table 55. Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Product and Services
Table 56. Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Wuhan Institute of Biological Products Recent Developments/Updates
Table 58. Lanzhou Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 59. Lanzhou Institute of Biological Products Major Business
Table 60. Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Product and Services
Table 61. Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Lanzhou Institute of Biological Products Recent Developments/Updates
Table 63. Global Measles Attenuated Live Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Measles Attenuated Live Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Measles Attenuated Live Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in Measles Attenuated Live Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Measles Attenuated Live Vaccine Production Site of Key Manufacturer
Table 68. Measles Attenuated Live Vaccine Market: Company Product Type Footprint
Table 69. Measles Attenuated Live Vaccine Market: Company Product Application Footprint
Table 70. Measles Attenuated Live Vaccine New Market Entrants and Barriers to Market Entry
Table 71. Measles Attenuated Live Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Measles Attenuated Live Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Measles Attenuated Live Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Measles Attenuated Live Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Measles Attenuated Live Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Measles Attenuated Live Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global Measles Attenuated Live Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global Measles Attenuated Live Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Measles Attenuated Live Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Measles Attenuated Live Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Measles Attenuated Live Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Measles Attenuated Live Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global Measles Attenuated Live Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global Measles Attenuated Live Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Measles Attenuated Live Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Measles Attenuated Live Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Measles Attenuated Live Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Measles Attenuated Live Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global Measles Attenuated Live Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America Measles Attenuated Live Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Measles Attenuated Live Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Measles Attenuated Live Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Measles Attenuated Live Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Measles Attenuated Live Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Measles Attenuated Live Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Measles Attenuated Live Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Measles Attenuated Live Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Measles Attenuated Live Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Measles Attenuated Live Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Measles Attenuated Live Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Measles Attenuated Live Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Measles Attenuated Live Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Measles Attenuated Live Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Measles Attenuated Live Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Measles Attenuated Live Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Measles Attenuated Live Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Measles Attenuated Live Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Measles Attenuated Live Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Measles Attenuated Live Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Measles Attenuated Live Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Measles Attenuated Live Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Measles Attenuated Live Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Measles Attenuated Live Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Measles Attenuated Live Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Measles Attenuated Live Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Measles Attenuated Live Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Measles Attenuated Live Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Measles Attenuated Live Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Measles Attenuated Live Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Measles Attenuated Live Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Measles Attenuated Live Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Measles Attenuated Live Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Measles Attenuated Live Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Measles Attenuated Live Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Measles Attenuated Live Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Measles Attenuated Live Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Measles Attenuated Live Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Measles Attenuated Live Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Measles Attenuated Live Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Measles Attenuated Live Vaccine Raw Material
Table 131. Key Manufacturers of Measles Attenuated Live Vaccine Raw Materials
Table 132. Measles Attenuated Live Vaccine Typical Distributors
Table 133. Measles Attenuated Live Vaccine Typical Customers
List of Figures
Figure 1. Measles Attenuated Live Vaccine Picture
Figure 2. Global Measles Attenuated Live Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Measles Attenuated Live Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Powder Examples
Figure 5. Liquid Examples
Figure 6. Global Measles Attenuated Live Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Measles Attenuated Live Vaccine Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Global Measles Attenuated Live Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Measles Attenuated Live Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Measles Attenuated Live Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Measles Attenuated Live Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Measles Attenuated Live Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Measles Attenuated Live Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Measles Attenuated Live Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Measles Attenuated Live Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Measles Attenuated Live Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Measles Attenuated Live Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Measles Attenuated Live Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Measles Attenuated Live Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Measles Attenuated Live Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Measles Attenuated Live Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Measles Attenuated Live Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Measles Attenuated Live Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Measles Attenuated Live Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Measles Attenuated Live Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Measles Attenuated Live Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Measles Attenuated Live Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Measles Attenuated Live Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Measles Attenuated Live Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Measles Attenuated Live Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Measles Attenuated Live Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Measles Attenuated Live Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Measles Attenuated Live Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Measles Attenuated Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Measles Attenuated Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Measles Attenuated Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Measles Attenuated Live Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Measles Attenuated Live Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Measles Attenuated Live Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Measles Attenuated Live Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Measles Attenuated Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Measles Attenuated Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Measles Attenuated Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Measles Attenuated Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Measles Attenuated Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Measles Attenuated Live Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Measles Attenuated Live Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Measles Attenuated Live Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Measles Attenuated Live Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 52. China Measles Attenuated Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Measles Attenuated Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Measles Attenuated Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Measles Attenuated Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Measles Attenuated Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Measles Attenuated Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Measles Attenuated Live Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Measles Attenuated Live Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Measles Attenuated Live Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Measles Attenuated Live Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Measles Attenuated Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Measles Attenuated Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Measles Attenuated Live Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Measles Attenuated Live Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Measles Attenuated Live Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Measles Attenuated Live Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Measles Attenuated Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Measles Attenuated Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Measles Attenuated Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Measles Attenuated Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Measles Attenuated Live Vaccine Market Drivers
Figure 73. Measles Attenuated Live Vaccine Market Restraints
Figure 74. Measles Attenuated Live Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Measles Attenuated Live Vaccine in 2022
Figure 77. Manufacturing Process Analysis of Measles Attenuated Live Vaccine
Figure 78. Measles Attenuated Live Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の麻疹弱毒生ワクチン市場2023年：企業・地域・タイプ・用途別分析(Global Measles Attenuated Live Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の生ワクチン＆弱毒化ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 弱毒生水痘ワクチンの世界市場見通し2023年-2029年
  • 弱毒生インフルエンザワクチン（LAIV）の世界市場見通し2023年-2029年
  • 生ワクチン&弱毒化ワクチンのグローバル市場予測2023-2029

    • ◆H&Iグローバルリサーチのお客様（例）◆